Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients
about
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safetyA systematic review on drug interactions in oncology.Level of evidence for therapeutic drug monitoring of taxanes.Predictive biomarkers in breast cancer: their value in neoadjuvant chemotherapy.Multi-layered polymeric nanoparticles for pH-responsive and sequenced release of theranostic agents.Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells.Gemcitabine, epirubicin and paclitaxel: pharmacokinetic and pharmacodynamic interactions in advanced breast cancer.Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity.Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.Myxofibrosarcoma primary cultures: molecular and pharmacological profile.A Prospective Study to Evaluate the Effect of Paclitaxel on Cardiac Ejection Fraction.Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma.Hepatic uptake of epirubicin by isolated rat hepatocytes and its biliary excretion after intravenous infusion in rats.
P2860
Q36625974-1403AD8A-21F9-4061-B22D-5A3FD53CA20AQ36659821-0D4DE3F2-811E-4371-852C-2772F0F4571DQ37788732-1D8794FD-96E0-42CF-8D91-549EB24C07A7Q38047337-484B17B9-D222-440A-81B4-EC54F588D47AQ38889924-E5AD656A-3732-4F49-9985-B8EA158B93BEQ40037006-39235FA6-C6D9-4D89-BA23-601032E8D03AQ44067892-7E8EC5B5-EE35-4B83-B21F-3EC7B1EE7845Q46987305-5880F6CD-8620-4B23-B936-4659C65B2525Q47239615-D21BB765-88DA-4CE2-A3EB-008743B7944CQ49956275-7E325F67-500D-4FDA-95E4-C8CE952727DCQ50085564-D57DDA3A-A095-4E55-A9C4-C9EDB24FAC71Q51285275-87E75911-FB4B-47D5-8873-FA3B38B1018BQ53252177-8628118D-4103-4DAE-8B2B-7EE57E6B772B
P2860
Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Pharmacokinetics and pharmacod ...... icin in breast cancer patients
@ast
Pharmacokinetics and pharmacod ...... icin in breast cancer patients
@en
type
label
Pharmacokinetics and pharmacod ...... icin in breast cancer patients
@ast
Pharmacokinetics and pharmacod ...... icin in breast cancer patients
@en
prefLabel
Pharmacokinetics and pharmacod ...... icin in breast cancer patients
@ast
Pharmacokinetics and pharmacod ...... icin in breast cancer patients
@en
P2093
P2860
P50
P1476
Pharmacokinetics and pharmacod ...... icin in breast cancer patients
@en
P2093
Barbara Salvadori
Editta Baldini
Federico Innocenti
Guido Bocci
Mario Del Tacca
Stefano Fogli
P2860
P304
P356
10.1046/J.1365-2125.2002.01579.X
P407
P577
2002-05-01T00:00:00Z